Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals
Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 1996-11, Vol.40 (11), p.2664-2668 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2668 |
|---|---|
| container_issue | 11 |
| container_start_page | 2664 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 40 |
| creator | BEEN-TIKTAK, A. M. M WILLIAMS, I BORLEFFS, J. C. C VREHEN, H. M RICHENS, J ALDAM, D VAN LOON, A. M LOVEDAY, C BOUCHER, C. A. B WARD, P WELLER, I. V. D |
| description | Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.40.11.2664 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2471950</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15760936</sourcerecordid><originalsourceid>FETCH-LOGICAL-a509t-19df10a62b09b8787f85ae92911a390f4bafdac8f13eacd2cae7b5f96670ae083</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMo67h69SY0Il7cHpP-SCeHPQyDX7DgQT2H6qSyk6U7GZPukfn3pplhWA-eUqGep4rkJeQ1o2vGKvFxs9mum6VeV5w3T8iKUSlK3kr-lKwo5bxsBG2ekxcpPdB8byW9IldCsroR3YqEH2BxOt4UUxgwgtd4U4A3BVrrNOhjEWwBEx5cNM5j4XwB6TjupzDC5HSxm0fwhRvH2QeDWXHos5TxOZXOW9QTmmwZd3BmhiG9JM9sPvDV-bwmvz5_-rn9Wt59__Jtu7kroaVyKpk0llHgVU9lLzrRWdECykoyBrWktunBGtDCshpBm0oDdn1rJecdBaSivia3p7n7uR_RaPRThEHtoxshHlUAp_7teLdT9-GgGK9bufjvz34Mv2dMkxpd0jgM4DHMSbG241TWPIPrE6hjSCmivexgVC0JqZyQapZaLQll4cNJgDRW6iHM0eeP-D_95vE7LsPPAeb-u3MfkobBLhG6dMGqpmOypRl7e8J27n73x0VUebsC0I93_QUTKbUZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15760936</pqid></control><display><type>article</type><title>Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>BEEN-TIKTAK, A. M. M ; WILLIAMS, I ; BORLEFFS, J. C. C ; VREHEN, H. M ; RICHENS, J ; ALDAM, D ; VAN LOON, A. M ; LOVEDAY, C ; BOUCHER, C. A. B ; WARD, P ; WELLER, I. V. D</creator><creatorcontrib>BEEN-TIKTAK, A. M. M ; WILLIAMS, I ; BORLEFFS, J. C. C ; VREHEN, H. M ; RICHENS, J ; ALDAM, D ; VAN LOON, A. M ; LOVEDAY, C ; BOUCHER, C. A. B ; WARD, P ; WELLER, I. V. D</creatorcontrib><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.40.11.2664</identifier><identifier>PMID: 8913487</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adult ; Anti-HIV Agents ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; CD4 Lymphocyte Count ; Clinical Trial ; Double-Blind Method ; HIV Infections ; HIV Infections - drug therapy ; HIV Infections - immunology ; HIV Infections - virology ; human immunodeficiency virus ; Humans ; Male ; Medical sciences ; Multicenter Study ; Pharmacology. Drug treatments ; Piperazines ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Randomized Controlled Trial</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1996-11, Vol.40 (11), p.2664-2668</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a509t-19df10a62b09b8787f85ae92911a390f4bafdac8f13eacd2cae7b5f96670ae083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC163598/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC163598/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2471950$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8913487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BEEN-TIKTAK, A. M. M</creatorcontrib><creatorcontrib>WILLIAMS, I</creatorcontrib><creatorcontrib>BORLEFFS, J. C. C</creatorcontrib><creatorcontrib>VREHEN, H. M</creatorcontrib><creatorcontrib>RICHENS, J</creatorcontrib><creatorcontrib>ALDAM, D</creatorcontrib><creatorcontrib>VAN LOON, A. M</creatorcontrib><creatorcontrib>LOVEDAY, C</creatorcontrib><creatorcontrib>BOUCHER, C. A. B</creatorcontrib><creatorcontrib>WARD, P</creatorcontrib><creatorcontrib>WELLER, I. V. D</creatorcontrib><title>Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adult</subject><subject>Anti-HIV Agents</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count</subject><subject>Clinical Trial</subject><subject>Double-Blind Method</subject><subject>HIV Infections</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>human immunodeficiency virus</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multicenter Study</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Randomized Controlled Trial</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU2LFDEQhoMo67h69SY0Il7cHpP-SCeHPQyDX7DgQT2H6qSyk6U7GZPukfn3pplhWA-eUqGep4rkJeQ1o2vGKvFxs9mum6VeV5w3T8iKUSlK3kr-lKwo5bxsBG2ekxcpPdB8byW9IldCsroR3YqEH2BxOt4UUxgwgtd4U4A3BVrrNOhjEWwBEx5cNM5j4XwB6TjupzDC5HSxm0fwhRvH2QeDWXHos5TxOZXOW9QTmmwZd3BmhiG9JM9sPvDV-bwmvz5_-rn9Wt59__Jtu7kroaVyKpk0llHgVU9lLzrRWdECykoyBrWktunBGtDCshpBm0oDdn1rJecdBaSivia3p7n7uR_RaPRThEHtoxshHlUAp_7teLdT9-GgGK9bufjvz34Mv2dMkxpd0jgM4DHMSbG241TWPIPrE6hjSCmivexgVC0JqZyQapZaLQll4cNJgDRW6iHM0eeP-D_95vE7LsPPAeb-u3MfkobBLhG6dMGqpmOypRl7e8J27n73x0VUebsC0I93_QUTKbUZ</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>BEEN-TIKTAK, A. M. M</creator><creator>WILLIAMS, I</creator><creator>BORLEFFS, J. C. C</creator><creator>VREHEN, H. M</creator><creator>RICHENS, J</creator><creator>ALDAM, D</creator><creator>VAN LOON, A. M</creator><creator>LOVEDAY, C</creator><creator>BOUCHER, C. A. B</creator><creator>WARD, P</creator><creator>WELLER, I. V. D</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>19961101</creationdate><title>Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals</title><author>BEEN-TIKTAK, A. M. M ; WILLIAMS, I ; BORLEFFS, J. C. C ; VREHEN, H. M ; RICHENS, J ; ALDAM, D ; VAN LOON, A. M ; LOVEDAY, C ; BOUCHER, C. A. B ; WARD, P ; WELLER, I. V. D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a509t-19df10a62b09b8787f85ae92911a390f4bafdac8f13eacd2cae7b5f96670ae083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Anti-HIV Agents</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count</topic><topic>Clinical Trial</topic><topic>Double-Blind Method</topic><topic>HIV Infections</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>human immunodeficiency virus</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multicenter Study</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Randomized Controlled Trial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BEEN-TIKTAK, A. M. M</creatorcontrib><creatorcontrib>WILLIAMS, I</creatorcontrib><creatorcontrib>BORLEFFS, J. C. C</creatorcontrib><creatorcontrib>VREHEN, H. M</creatorcontrib><creatorcontrib>RICHENS, J</creatorcontrib><creatorcontrib>ALDAM, D</creatorcontrib><creatorcontrib>VAN LOON, A. M</creatorcontrib><creatorcontrib>LOVEDAY, C</creatorcontrib><creatorcontrib>BOUCHER, C. A. B</creatorcontrib><creatorcontrib>WARD, P</creatorcontrib><creatorcontrib>WELLER, I. V. D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BEEN-TIKTAK, A. M. M</au><au>WILLIAMS, I</au><au>BORLEFFS, J. C. C</au><au>VREHEN, H. M</au><au>RICHENS, J</au><au>ALDAM, D</au><au>VAN LOON, A. M</au><au>LOVEDAY, C</au><au>BOUCHER, C. A. B</au><au>WARD, P</au><au>WELLER, I. V. D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>40</volume><issue>11</issue><spage>2664</spage><epage>2668</epage><pages>2664-2668</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>8913487</pmid><doi>10.1128/AAC.40.11.2664</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 1996-11, Vol.40 (11), p.2664-2668 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_2471950 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Adult Anti-HIV Agents Anti-HIV Agents - adverse effects Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences CD4 Lymphocyte Count Clinical Trial Double-Blind Method HIV Infections HIV Infections - drug therapy HIV Infections - immunology HIV Infections - virology human immunodeficiency virus Humans Male Medical sciences Multicenter Study Pharmacology. Drug treatments Piperazines Piperazines - adverse effects Piperazines - therapeutic use Randomized Controlled Trial |
| title | Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A51%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety,%20tolerance,%20and%20efficacy%20of%20atevirdine%20in%20asymptomatic%20human%20immunodeficiency%20virus-infected%20individuals&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=BEEN-TIKTAK,%20A.%20M.%20M&rft.date=1996-11-01&rft.volume=40&rft.issue=11&rft.spage=2664&rft.epage=2668&rft.pages=2664-2668&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.40.11.2664&rft_dat=%3Cproquest_pasca%3E15760936%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15760936&rft_id=info:pmid/8913487&rfr_iscdi=true |